Replies to post #173418 on Biotech Values

[genisi]

Thanks, the 2% discount is mentioned here as well:

http://www.biocentury.com/dailynews/company/2014-01-29/teva-prices-thrice-weekly-copaxone

Too small discount to encourage patient conversion, guess the main strategy is statments like the one made by Prof. Khan.